Literature DB >> 9696240

Basal hormone levels in women who use acetaminophen for menstrual pain.

D W Cramer1, R F Liberman, M D Hornstein, P McShane, D Powers, E Y Li, R Barbieri.   

Abstract

OBJECTIVE: To compare basal gonadotropin and estradiol levels between women using acetaminophen versus those using no or other types of analgesics.
DESIGN: Observational study.
SETTING: Three IVF clinics in greater Boston. PATIENT(S): Three hundred eighty-six women accepted for their first IVF treatment who completed questionnaires recording medical history, including analgesic use for menstrual pain, and who had blood drawn during the menstrual phase of a cycle before treatment. MAIN OUTCOME MEASURE(S): Basal FSH, LH, and estradiol. RESULT(S): Basal hormone levels, especially LH, were lower for women who regularly used acetaminophen compared with women who used no medication or other types of analgesics. Lower hormone levels in acetaminophen users were consistently observed when women were subdivided by age, body mass index, smoking history, and degree of menstrual pain-features that might have influenced analgesic use or hormone levels. CONCLUSION(S): This study provides preliminary evidence that acetaminophen may lower gonadotropin and estradiol levels and offers a biologic basis for the epidemiologic observation that acetaminophen use may reduce the risk of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696240     DOI: 10.1016/s0015-0282(98)00153-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Effects of over-the-counter analgesic use on reproductive hormones and ovulation in healthy, premenopausal women.

Authors:  R A Matyas; S L Mumford; K C Schliep; K A Ahrens; L A Sjaarda; N J Perkins; A C Filiberto; D Mattison; S M Zarek; J Wactawski-Wende; E F Schisterman
Journal:  Hum Reprod       Date:  2015-05-06       Impact factor: 6.918

2.  Paracetamol use and risk of ovarian cancer: a meta-analysis.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

3.  Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.

Authors:  Akila N Viswanathan; Diane Feskanich; Eva S Schernhammer; Susan E Hankinson
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

4.  Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence.

Authors:  Xuehong Zhang; Stephanie A Smith-Warner; Laura C Collins; Bernard Rosner; Walter C Willett; Susan E Hankinson
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

5.  Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.

Authors:  Britton Trabert; Elizabeth M Poole; Emily White; Kala Visvanathan; Hans-Olov Adami; Garnet L Anderson; Theodore M Brasky; Louise A Brinton; Renee T Fortner; Mia Gaudet; Patricia Hartge; Judith Hoffman-Bolton; Michael Jones; James V Lacey; Susanna C Larsson; Gerardo G Mackenzie; Leo J Schouten; Dale P Sandler; Katie O'Brien; Alpa V Patel; Ulrike Peters; Anna Prizment; Kim Robien; V Wendy Setiawan; Anthony Swerdlow; Piet A van den Brandt; Elisabete Weiderpass; Lynne R Wilkens; Alicja Wolk; Nicolas Wentzensen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

6.  Acetaminophen Modulates the Expression of Steroidogenesis-Associated Genes and Estradiol Levels in Human Placental JEG-3 Cells.

Authors:  Kezia A Addo; Niharika Palakodety; Rebecca C Fry
Journal:  Toxicol Sci       Date:  2021-01-06       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.